Preparation and In Vitro Characteristics of Lactoferrin-loaded Chitosan Microparticles

REFERENCES

• Alsarra I. A., El-Bagory I., Bayomi M. A. Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets. Drug Dev. Ind. Pharm. 2005; 31: 385–395
   PubMed Web of Science ®Google Scholar
• Arnold R. R., Brewer M., Gauthier J. J. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect. Immun. 1980; 28: 893–898
   PubMed Web of Science ®Google Scholar
• Arnold R. R., Cole M. F., McGhee J. R. A bactericidal effect for human lactoferrin. Science 1977; 197: 263–265
   PubMed Web of Science ®Google Scholar
• Chen Y., Willmott N., Anderson J., Florence A. T. Comparison of albumin and casein microspheres as a carrier for doxorubicin. J. Pharm. Pharmacol. 1987; 39: 978–985
   PubMed Web of Science ®Google Scholar
• Cirioni O., Giacometti A., Barchiesi F., Scalise G. Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline. J. Antimicrob. Chemother. 2000; 46: 577–582
   PubMed Web of Science ®Google Scholar
• Haversen L. A., Engberg I., Baltzer L., Dolphin G., Hanson L. A., Mattsby-Baltzer I. Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect. Immun. 2000; 68: 5816–5823
   PubMed Web of Science ®Google Scholar
• Hejazi R., Amiji M. Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres. Int. J. Pharm. 2002; 235: 87–94
   PubMed Web of Science ®Google Scholar
• Hejazi R., Amiji M. Chitosan-based gastrointestinal delivery systems. J. Control Release 2003; 89: 151–165
   PubMed Web of Science ®Google Scholar
• Hori M., Onishi H., Machida Y. Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system. Int. J. Pharm. 2005; 297: 223–234
   PubMed Web of Science ®Google Scholar
• Hu Y., Jiang X., Ding Y., Ge H., Yuan Y., Yang C. Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials 2002; 23: 3193–3201
   PubMed Web of Science ®Google Scholar
• Iigo M., Kuhara T., Ushida Y., Sekine K., Moore M. A., Tsuda H. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin. Exp. Metastasis 1999; 17: 35–40
   PubMed Web of Science ®Google Scholar
• Ishikado A., Imanaka H., Takeuchi T., Harada E., Makino T. Liposomalization of lactoferrin enhanced it's anti-inflammatory effects via oral administration. Biol. Pharm. Bull. 2005; 28: 1717–1721
   PubMed Web of Science ®Google Scholar
• Jenssen H. Anti herpes simplex virus activity of lactoferrin/lactoferricin- an example of antiviral activity of antimicrobial protein/peptide. Cell. Mol. Life Sci. 2005; 62: 3002–3013
   PubMed Web of Science ®Google Scholar
• Kaur I. P., Smitha R. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev. Ind. Pharm. 2002; 28: 353–369
   PubMed Web of Science ®Google Scholar
• Kuipers M. E., Heegsma J., Bakker H. I., Meijer D. K., Swart P. J., Frijlink E. W., Eissens A. C., de Vries-Hospers H. G., van den Berg J. J. Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis. Drug Deliv. 2002; 9: 31–38
   PubMed Web of Science ®Google Scholar
• Lee N. Y., Kawai K., Nakamura I., Tanaka T., Kumura H., Shimazaki K. Susceptibilities against bovine lactoferrin with microorganisms isolated from mastitic milk. J. Vet. Med. Sci. 2004; 66: 1267–1269
   PubMed Web of Science ®Google Scholar
• Legrand D., Elass E., Pierce A., Mazurier J. Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties. Biometals 2004; 17: 225–229
   PubMed Web of Science ®Google Scholar
• Mi F. L., Tan Y. C., Liang H. F., Sung H. W. In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials 2002; 23: 181–191
   PubMed Web of Science ®Google Scholar
• Nafee N. A., Ismail F. A., Boraie N. A., Mortada L. M. Mucoadhesive delivery systems. II. Formulation and in-vitro/in-vivo evaluation of buccal mucoadhesive tablets containing water-soluble drugs. Drug Dev. Ind. Pharm. 2004; 30: 995–1004
   PubMed Web of Science ®Google Scholar
• Orsi N. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 2004; 17: 189–196
   PubMed Web of Science ®Google Scholar
• Samaranayake Y. H., Samaranayake L. P., Pow E. H., Beena V. T., Yeung K. W. Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort. J. Clin. Microbiol. 2001; 39: 3296–3302
   PubMed Web of Science ®Google Scholar
• Shimizu H. Development of an enteric-coated lactoferrin tablet and its application. Biometals 2004; 17: 343–347
   PubMed Web of Science ®Google Scholar
• Shimoda J., Onishi H., Machida Y. Bioadhesive characteristics of chitosan microspheres to the mucosa of rat small intestine. Drug Dev. Ind. Pharm. 2001; 27: 567–576
   PubMed Web of Science ®Google Scholar
• Suzuki Y. A., Lopez V., Lonnerdal B. Mammalian lactoferrin receptors: structure and function. Cell Mol. Life Sci. 2005; 62: 2560–2575
   PubMed Web of Science ®Google Scholar
• Tabata Y., Ikada Y. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 1988; 9: 356–362
   PubMed Web of Science ®Google Scholar
• Takakura N., Wakabayashi H., Ishibashi H., Teraguchi S., Tamura Y., Yamaguchi H., Abe S. Oral lactoferrin treatment of experimental oral candidiasis in mice. Antimicrob. Agents Chemother. 2003; 47: 2619–2623
   PubMed Web of Science ®Google Scholar
• Trif M., Guillen C., Vaughan D. M., Telfer J. M., Brewer J. M., Roseanu A., Brock J.H. Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases. Exp. Biol. Med. 2001; 226: 559–564
   PubMed Web of Science ®Google Scholar
• Wakabayashi H., Abe S., Teraguchi S., Hayasawa H., Yamaguchi H. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob. Agents Chemother. 1998; 42: 1587–1591
   PubMed Web of Science ®Google Scholar
• Weinberg E. D. Iron and susceptibility to infectious disease. Science 1974; 184: 952–956
   PubMed Web of Science ®Google Scholar
• Yoshino T., Machida Y., Onishi H., Nagai T. Preparation and characterization of chitosan microspheres containing doxifluridine. Drug Dev. Ind. Pharm. 2003; 29: 417–427
   PubMed Web of Science ®Google Scholar